Characteristics of vaccine failures in a randomized placebo-controlled trial of inactivated influenza vaccine in children

Pediatric Infectious Disease Journal

Volumn 33, Issue 2, 2014, Pages

  Ng, Sophia ^a,b   Ni, Michael Y ^a   Fang, Vicky Jing ^a   Ip, Dennis Kai Ming ^a   Chan, Kwok Hung ^a   Leung, Gabriel Matthew ^a   Peiris, Joseph Sriyal Malik ^a   Cowling, Benjamin John ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b PRINCETON UNIVERSITY   (United States)

Author keywords

illness; randomized controlled trial; vaccine; viral shedding

Indexed keywords

INFLUENZA VACCINE; PLACEBO;

ADOLESCENT; ANTIBODY RESPONSE; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE DURATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; HEMAGGLUTINATION; HUMAN; INFLUENZA B; INFLUENZA VACCINATION; INFLUENZA VIRUS B; MAJOR CLINICAL STUDY; PRESCHOOL CHILD; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SEASONAL INFLUENZA; SERUM; SYMPTOM; VACCINE FAILURE; VIRUS LOAD; VIRUS SHEDDING;

ADOLESCENT; ANTIBODIES, VIRAL; CHILD; DOUBLE-BLIND METHOD; HUMANS; INFLUENZA B VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; PLACEBOS; VACCINES, INACTIVATED; VIRUS SHEDDING;

EID: 84893018083     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000064     Document Type: Article

References (21)

1. Osterholm MT, Kelley NS, Sommer A, et al. Efficacy and effectiveness of influenza vaccines a systematic review and meta-analysis. Lancet Infect Dis. 2012;1236-44
2. Petrie JG, Ohmit SE, Johnson E, et al. Efficacy studies of influenza vaccines effect of end points used and characteristics of vaccine failures. J Infect Dis. 2011;2031309-1315
3. Basta NE, Halloran ME, Matrajt L, et al. Estimating influenza vaccine efficacy from challenge and community-based study data. Am J Epidemiol. 2008;1681343-1352
4. Cowling BJ, Ng S, Ma ES, et al. Protective efficacy against pandemic influenza of seasonal influenza vaccination in children in Hong Kong a randomized controlled trial. Clin Infect Dis. 2012;55695-702
5. Ip DK, Schutten M, Fang VJ, et al. Validation of self-swab for virologic confirmation of influenza virus infections in a community setting. J Infect Dis. 2012;205631-634
6. Pan W, Louis TA. A linear mixed-effects model for multivariate censored data. Biometrics. 2000;56160-166
7. Collett D. Modelling survival data in medical research. 2 ed. FL Chapman& HallCRC; 2003 National Institute for Medical Research. Report prepared for the WHO annual consultation on the composition of influenza vaccine for the Southern Hemisphere; September 2010
8. Johnson PR, Feldman S, Thompson JM, et al. Immunity to influenza A virus infection in young children a comparison of natural infection, live cold-adapted vaccine, and inactivated vaccine. J Infect Dis. 1986;154121-127
9. Suess T, Remschmidt C, Schink SB, et al. Comparison of shedding characteristics of seasonal influenza virus (sub)types and influenza A(H1N1) pdm09; Germany, 2007-2011. PLoS One. 2012;7e51653
10. Kamada M, Nagai T, Kumagai T, et al. Efficacy of inactivated trivalent influenza vaccine in alleviating the febrile illness of culture-confirmed influenza in children in the 2000-2001 influenza season. Vaccine. 2006;243618-3623
11. Couch RB, Atmar RL, Franco LM, et al. Antibody correlates and predictors of immunity to naturally occurring influenza in humans and the importance of antibody to the neuraminidase. J Infect Dis. 2013;207974-981
12. Monto AS, Kendal AP. Effect of neuraminidase antibody on Hong Kong influenza. Lancet. 1973;1623-625
13. Couch RB, Atmar RL, Keitel WA, et al. Randomized comparative study of the serum antihemagglutinin and antineuraminidase antibody responses to six licensed trivalent influenza vaccines. Vaccine. 2012;31190-195
14. Couch RB. Seasonal inactivated influenza virus vaccines. Vaccine. 2008;26Suppl 4D5-D9
15. Ramakrishnan A, Althoff KN, Lopez JA, et al. Differential serum cytokine responses to inactivated and live attenuated seasonal influenza vaccines. Cytokine. 2012;60661-666
16. He XS, Holmes TH, Zhang C, et al. Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines. J Virol. 2006;8011756-11766
17. Ohmit SE, Petrie JG, Cross RT, et al. Influenza hemagglutination- inhibition antibody titer as a correlate of vaccine-induced protection. J Infect Dis. 2011;2041879-1885
18. Hudgens MG, Halloran ME. Causal Vaccine Effects on Binary Postinfection Outcomes. J Am Stat Assoc. 2006;10151-64
19. Horby P, Mai le Q, Fox A, et al. The epidemiology of interpandemic and pandemic influenza in Vietnam, 2007-2010 the Ha Nam household cohort study I. Am J Epidemiol. 2012;1751062-1074
20. Skowronski DM, De Serres G, Crowcroft NS, et al. Association between the 2008-09 seasonal influenza vaccine and pandemic H1N1 illness during Spring-Summer 2009 four observational studies from Canada. PLoS Med. 2010;7e1000258
21. Chiu SS, Peiris JS, Chan KH, et al. Immunogenicity and safety of intradermal influenza immunization at a reduced dose in healthy children. Pediatrics. 2007;1191076-1082